|
Re: Just a guess on my part....
|
3
|
Resverlogix Corp.
|
May 09, 2018 04:46PM
|
|
Re: True to Your Heart
|
3
|
Resverlogix Corp.
|
Feb 25, 2020 10:36AM
|
|
Re: The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
|
3
|
Resverlogix Corp.
|
Sep 29, 2017 03:32PM
|
|
Re: New Zealand Renal Phase 1 Trial with RVX-208
|
3
|
Resverlogix Corp.
|
Jun 20, 2016 05:04PM
|
|
Re: Slide 27 - I would get rid of it....
|
3
|
Resverlogix Corp.
|
Sep 18, 2016 07:12AM
|
|
Re: Bear AZ
|
3
|
Resverlogix Corp.
|
Sep 26, 2019 06:30AM
|
|
AHA BETonMACE Slides are up
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 04:14PM
|
|
New paper on interplay/synergy of BET inhibitors and PD-L1 inhibition
|
3
|
Zenith Epigenetics
|
Mar 02, 2017 10:51AM
|
|
CVOTs on the Horizon
|
3
|
Resverlogix Corp.
|
Oct 01, 2018 04:04PM
|
|
Re: The new competitors: SGLT2 inhibitors and GLP-1 Receptor Agonists
|
3
|
Resverlogix Corp.
|
Jun 14, 2016 11:25AM
|
|
Re: Resverlogix presenting at Vascular Discovery 2019 next week
|
3
|
Resverlogix Corp.
|
May 11, 2019 11:18AM
|
|
Re: A few comments
|
3
|
Resverlogix Corp.
|
Jan 12, 2017 11:29AM
|
|
Re: Coronary Artery Calcium Score
|
3
|
Resverlogix Corp.
|
Feb 17, 2019 09:16PM
|
|
Re: The BET/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice
|
3
|
Resverlogix Corp.
|
Sep 29, 2017 03:55PM
|
|
Re: Resverlogix presenting at Vascular Discovery 2019 next week
|
3
|
Resverlogix Corp.
|
May 14, 2019 05:23PM
|
|
Bioasis April 2018 Corporate Presentation
|
3
|
BIOASIS TECHNOLOGIES INC
|
Apr 10, 2018 10:56PM
|
|
Re: BIO CEO Slides Up
|
3
|
Resverlogix Corp.
|
Feb 13, 2019 01:18PM
|
|
Resverlogix Announces Commencement of Patient Enrollment and Dosing in a Phase 2b Trial for a Promising Canadian-Developed COVID-19 Treatment
|
3
|
Resverlogix Corp.
|
Jan 18, 2022 10:50AM
|
|
Re: Statistical Significance
|
3
|
Resverlogix Corp.
|
Apr 13, 2019 02:36PM
|
|
Re: Mr. Paradis' Smoke Screen
|
3
|
Resverlogix Corp.
|
Jul 29, 2016 06:45PM
|
